Unicycive Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UNCY research report →
Range $22 – $22
Price Chart
About the company
Unicycive Therapeutics, Inc. is a U. S.
- CEO
- Shalabh K. Gupta
- IPO
- 2021
- Employees
- 21
- HQ
- Mountain View, CA, US
Get TickerSpark's AI analysis on UNCY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $112.94M
- P/E
- -2.53
- Fwd P/E
- 2.31
- PEG
- -0.03
- P/S
- 0.00
- P/B
- 2.14
- EV/EBITDA
- -2.01
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -88.81%
- ROIC
- -61.44%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-572,000+0.0%
- Op Income
- $-29,517,000
- Net Income
- $-26,555,000+27.7%
- EPS
- $-1.67+70.4%
- OCF Growth
- -9.6%
- FCF Growth
- -9.4%
- 52W High
- $8.74
- 52W Low
- $3.93
- 50D MA
- $5.07
- 200D MA
- $6.29
- Beta
- 1.82
- RSI (14)
- 32
- Avg Volume
- 850.95K
No earnings-call transcripts are available for UNCY yet.
- Free Float
- 90.9%
- Shares Outstanding
- 26.70M
- Float Shares
- 24.28M
of shares held by institutions
57 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.41M | ▲ 1.38M |
| Nantahala Capital Management, LLC | 1.40M | ▲ 462.25K |
| Vanguard Capital Management LLC | 1.07M | ▲ 260.05K |
| Octagon Capital Advisors LP | 1.00M | 0 |
| Vanguard Group Inc | 788.59K | ▲ 129.71K |
| Geode Capital Management, LLC | 564.02K | ▲ 360.27K |
| Vivo Capital, LLC | 550.00K | ▼ 1.24M |
| Marshall Wace, Llp | 547.86K | ▲ 392.92K |
| Logos Global Management LP | 473.56K | 0 |
| State Street Corp | 450.16K | ▲ 370.13K |
| Diametric Capital, LP | 374.13K | ▲ 293.77K |
| J. Goldman & Co LP | 327.35K | ▲ 327.35K |
Held by 88 ETFs
Biggest fund positions in UNCY by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 1, 26 | Manning Meredith | other | 0 |
| May 14, 26 | Kenkare-Mitra Sara | other | 47,941 |
| May 14, 26 | Laumas Sandeep | other | 47,941 |
| May 14, 26 | Gupta Shalabh K. | other | 762,200 |
| May 14, 26 | Kenkare-Mitra Sara | other | 42,100 |
| May 14, 26 | Kenkare-Mitra Sara | other | 84,200 |
| May 14, 26 | Jermasek Douglas | other | 169,500 |
| May 14, 26 | Gupta Pramod | other | 169,500 |
| May 14, 26 | Townsend John | other | 169,500 |
| May 14, 26 | Laumas Sandeep | other | 42,100 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our UNCY coverage
Recent articles, reports, and earnings notes.
No research on UNCY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UNCY report →ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
newsfilecorp.com · Oct 6
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
newsfilecorp.com · Oct 6
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
globenewswire.com · Oct 6
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC
globenewswire.com · Oct 6
ROSEN, A LONGSTANDING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
newsfilecorp.com · Oct 5
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
globenewswire.com · Oct 5
Deadline Alert: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com · Oct 5
UNCY DEADLINE: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
globenewswire.com · Oct 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.